INNOVIVA, INC. Financing Cash Flow
INNOVIVA, INC. (INVA) reported Financing Cash Flow of -$49.55 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- INNOVIVA, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$29.41M, a 2458.06% decline year-over-year.
- INNOVIVA, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$20.15M, a 11108.74% decline year-over-year.
- INNOVIVA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$3.72M, a 749.39% decline year-over-year.
- INNOVIVA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $10.84M, a 5038.39% increase year-over-year.
- INNOVIVA, INC. net cash provided by (used in) financing activities for fiscal 2025 was $8.55M.
- INNOVIVA, INC. net cash provided by (used in) financing activities for fiscal 2024 was -$13.45M.
- INNOVIVA, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$171.84M.
- INNOVIVA, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$55.57M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$29.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$49.55M 10-Q · filed 2026-08-05 | -$53.27M derived: sum of 3 quarters · filed 2026-08-05 | -$42.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$20.15M 10-Q · filed 2026-05-06 | -$23.87M derived: sum of 2 quarters · filed 2026-05-06 | -$13.03M derived: sum of 3 quarters · filed 2026-05-06 | -$11.78M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $7.12M derived: sum of 2 quarters · filed 2026-02-25 | $8.37M derived: sum of 3 quarters · filed 2026-08-05 | $8.55M 10-K · filed 2026-02-25 |
| 2025-09-30 | $10.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $12.09M derived: sum of 2 quarters · filed 2026-08-05 | $12.27M 10-Q · filed 2025-11-05 | $12.85M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.43M 10-Q · filed 2026-08-05 | $2.00M derived: sum of 3 quarters · filed 2026-08-05 | $2.21M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $183.00K 10-Q · filed 2026-05-06 | $756.00K derived: sum of 2 quarters · filed 2026-05-06 | $967.00K derived: sum of 3 quarters · filed 2026-05-06 | -$4.11M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $573.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $784.00K derived: sum of 2 quarters · filed 2026-02-25 | -$4.29M derived: sum of 3 quarters · filed 2026-02-25 | -$13.45M 10-K · filed 2026-02-25 |
| 2024-09-30 | $211.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$4.86M derived: sum of 2 quarters · filed 2025-11-05 | -$14.03M 10-Q · filed 2025-11-05 | -$28.61M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$14.24M 10-Q · filed 2025-08-06 | -$28.83M derived: sum of 3 quarters · filed 2026-02-25 | -$39.91M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$9.16M 10-Q · filed 2025-05-07 | -$23.75M derived: sum of 2 quarters · filed 2026-02-25 | -$34.84M derived: sum of 3 quarters · filed 2026-02-25 | -$44.04M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$14.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$25.67M derived: sum of 2 quarters · filed 2026-02-25 | -$34.88M derived: sum of 3 quarters · filed 2026-02-25 | -$171.84M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$11.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$20.29M derived: sum of 2 quarters · filed 2024-11-06 | -$157.25M 10-Q · filed 2024-11-06 | -$167.25M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | -$9.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$146.17M 10-Q · filed 2024-07-31 | -$156.17M derived: sum of 3 quarters · filed 2025-02-26 | -$252.33M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | -$136.96M 10-Q · filed 2024-05-08 | -$146.96M derived: sum of 2 quarters · filed 2025-02-26 | -$243.13M derived: sum of 3 quarters · filed 2025-02-26 | -$252.86M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$106.16M derived: sum of 2 quarters · filed 2025-02-26 | -$115.90M derived: sum of 3 quarters · filed 2025-02-26 | -$55.57M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$96.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$105.90M derived: sum of 2 quarters · filed 2023-11-01 | -$45.57M 10-Q · filed 2023-11-01 | -$57.63M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | -$9.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $50.60M 10-Q · filed 2023-08-02 | $38.53M derived: sum of 3 quarters · filed 2024-03-05 | $33.67M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $60.33M 10-Q · filed 2023-05-09 | $48.27M derived: sum of 2 quarters · filed 2024-03-05 | $43.40M derived: sum of 3 quarters · filed 2024-03-05 | -$370.86M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | -$12.07M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05 | -$16.93M derived: sum of 2 quarters · filed 2024-03-05 | -$431.19M derived: sum of 3 quarters · filed 2024-03-05 | -$452.50M 10-K/A · filed 2024-03-05 |
| 2021-09-30 | -$4.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$419.12M derived: sum of 2 quarters · filed 2022-11-09 | -$440.43M 10-Q · filed 2022-11-09 | -$442.94M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$414.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$435.57M 10-Q · filed 2022-07-27 | -$438.07M derived: sum of 3 quarters · filed 2023-02-28 | -$438.09M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$21.31M 10-Q · filed 2022-05-05 | -$23.82M derived: sum of 2 quarters · filed 2023-02-28 | -$23.83M derived: sum of 3 quarters · filed 2023-02-28 | -$35.45M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$2.52M derived: sum of 2 quarters · filed 2023-02-28 | -$14.14M derived: sum of 3 quarters · filed 2023-02-28 | -$29.79M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$11.64M derived: sum of 2 quarters · filed 2021-10-27 | -$27.28M 10-Q · filed 2021-10-27 | -$41.03M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-06-30 | -$11.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$27.27M 10-Q · filed 2021-07-29 | -$41.02M derived: sum of 3 quarters · filed 2022-03-17 | -$51.49M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-03-31 | -$15.64M 10-Q · filed 2021-04-28 | -$29.39M derived: sum of 2 quarters · filed 2022-03-17 | -$39.86M derived: sum of 3 quarters · filed 2022-03-17 | -$39.66M derived: sum of 4 quarters · filed 2022-03-17 |
| 2019-12-31 | -$13.75M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17 | -$24.22M derived: sum of 2 quarters · filed 2022-03-17 | -$24.02M derived: sum of 3 quarters · filed 2022-03-17 | -$23.78M 10-K/A · filed 2022-03-17 |
| 2019-09-30 | -$10.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | -$10.27M derived: sum of 2 quarters · filed 2020-10-28 | -$10.03M 10-Q · filed 2020-10-28 | -$12.41M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $198.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $444.00K 10-Q · filed 2020-07-29 | -$1.94M derived: sum of 3 quarters · filed 2021-02-25 | -$114.19M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $246.00K 10-Q · filed 2020-04-29 | -$2.13M derived: sum of 2 quarters · filed 2021-02-25 | -$114.38M derived: sum of 3 quarters · filed 2021-02-25 | -$115.10M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$114.63M derived: sum of 2 quarters · filed 2021-02-25 | -$115.34M derived: sum of 3 quarters · filed 2021-02-25 | -$237.97M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$112.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$112.96M derived: sum of 2 quarters · filed 2019-10-30 | -$235.59M 10-Q · filed 2019-10-30 | -$322.65M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | -$715.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$123.34M 10-Q · filed 2019-07-24 | -$210.40M derived: sum of 3 quarters · filed 2020-02-19 | -$221.33M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | -$122.63M 10-Q · filed 2019-05-01 | -$209.69M derived: sum of 2 quarters · filed 2020-02-19 | -$220.62M derived: sum of 3 quarters · filed 2020-02-19 | -$277.45M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | -$87.06M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$97.99M derived: sum of 2 quarters · filed 2020-02-19 | -$154.83M derived: sum of 3 quarters · filed 2020-02-19 | -$163.19M 10-K · filed 2020-02-19 |
| 2017-09-30 | -$10.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$67.77M derived: sum of 2 quarters · filed 2018-10-31 | -$76.13M 10-Q · filed 2018-10-31 | -$95.72M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | -$56.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | -$65.20M 10-Q · filed 2018-07-26 | -$84.78M derived: sum of 3 quarters · filed 2019-02-19 | -$109.63M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | -$8.36M 10-Q · filed 2018-05-04 | -$27.95M derived: sum of 2 quarters · filed 2019-02-19 | -$52.79M derived: sum of 3 quarters · filed 2019-02-19 | -$79.59M derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | -$19.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -$44.43M derived: sum of 2 quarters · filed 2019-02-19 | -$71.22M derived: sum of 3 quarters · filed 2019-02-19 | -$97.57M 10-K · filed 2019-02-19 |
| 2016-09-30 | -$24.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$51.64M derived: sum of 2 quarters · filed 2017-11-03 | -$77.98M 10-Q · filed 2017-11-03 | -$103.75M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | -$26.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$53.14M 10-Q · filed 2017-08-08 | -$78.91M derived: sum of 3 quarters · filed 2018-02-23 | -$104.53M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | -$26.34M 10-Q · filed 2016-05-05 | -$52.12M derived: sum of 2 quarters · filed 2018-02-23 | -$77.73M derived: sum of 3 quarters · filed 2018-02-23 | -$105.56M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | -$25.77M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$51.38M derived: sum of 2 quarters · filed 2018-02-23 | -$79.21M derived: sum of 3 quarters · filed 2018-02-23 | -$106.92M 10-K · filed 2018-02-23 |
| 2015-09-30 | -$25.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$53.44M derived: sum of 2 quarters · filed 2016-11-03 | -$81.15M 10-Q · filed 2016-11-03 | -$90.90M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | -$27.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$55.53M 10-Q · filed 2016-08-04 | -$65.29M derived: sum of 3 quarters · filed 2017-02-28 | -$73.15M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | -$27.71M 10-Q · filed 2016-05-05 | -$37.46M derived: sum of 2 quarters · filed 2017-02-28 | -$45.32M derived: sum of 3 quarters · filed 2017-02-28 | $103.09M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | -$9.75M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$17.61M derived: sum of 2 quarters · filed 2017-02-28 | $130.80M derived: sum of 3 quarters · filed 2017-02-28 | $149.07M 10-K · filed 2017-02-28 |
| 2014-09-30 | -$7.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $140.56M derived: sum of 2 quarters · filed 2015-11-05 | $158.83M 10-Q · filed 2015-11-05 | $171.84M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | $148.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $166.69M 10-Q · filed 2015-08-06 | $179.71M derived: sum of 3 quarters · filed 2016-02-24 | $293.27M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | $18.27M 10-Q · filed 2015-05-08 | $31.29M derived: sum of 2 quarters · filed 2016-02-24 | $144.86M derived: sum of 3 quarters · filed 2016-02-24 | |
| 2013-12-31 | $13.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $126.59M derived: sum of 2 quarters · filed 2016-02-24 | $397.84M 10-K · filed 2016-02-24 | |
| 2013-09-30 | $113.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $384.82M 10-Q · filed 2014-11-04 | ||
| 2013-06-30 | $271.26M 10-Q · filed 2014-08-07 | |||
| 2012-12-31 | $235.87M 10-K · filed 2015-02-27 | |||
| 2011-06-30 | $21.44M 10-Q · filed 2011-08-03 | |||
| 2010-06-30 | $96.53M 10-Q · filed 2011-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |